| |
| |
|
| Insider
Information: |
Beeler Brian K |
| Relationship: |
EVP, General Counsel |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
62,775 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,776,533 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,775 |
|
|
| Total
Value |
$1,776,533 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, General Counsel |
2021-09-17 |
62,775 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-09-17 |
4 |
AS |
$107.91 |
$3,036,911 |
D/D |
(28,143) |
62,775 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-08-16 |
4 |
S |
$106.00 |
$7,939,188 |
D/D |
(74,898) |
90,918 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-08-16 |
4 |
OE |
$22.14 |
$1,458,074 |
D/D |
65,857 |
165,816 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-07-28 |
4 |
D |
$102.50 |
$263,733 |
D/D |
(2,573) |
99,959 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,806 |
102,532 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-03-31 |
4 |
AS |
$90.12 |
$2,419,181 |
D/D |
(26,844) |
95,677 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,571 |
123,217 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-02-17 |
4 |
D |
$87.17 |
$60,670 |
D/D |
(696) |
122,521 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-01-21 |
4 |
D |
$77.43 |
$141,387 |
D/D |
(1,826) |
121,646 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,120 |
123,472 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-01-05 |
4 |
D |
$73.28 |
$3,237,877 |
D/D |
(44,185) |
119,352 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
60,313 |
163,537 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,196 |
103,224 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-09-04 |
4 |
OE |
$7.61 |
$419,666 |
D/D |
28,143 |
64,028 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-06-01 |
4 |
AS |
$50.23 |
$119,045 |
D/D |
(2,370) |
35,885 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-05-06 |
4 |
AS |
$40.80 |
$1,958,515 |
D/D |
(48,000) |
37,206 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-04-29 |
4 |
AS |
$35.02 |
$556,118 |
D/D |
(15,880) |
85,206 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-04-16 |
4 |
AS |
$32.51 |
$292,615 |
D/D |
(9,000) |
101,086 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-04-07 |
4 |
AS |
$32.50 |
$9,653 |
D/D |
(297) |
110,086 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-04-06 |
4 |
AS |
$32.50 |
$77,025 |
D/D |
(2,370) |
110,383 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-02-19 |
4 |
D |
$36.06 |
$163,496 |
D/D |
(4,534) |
112,753 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,232 |
117,287 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-01-21 |
4/A |
D |
$38.25 |
$69,806 |
D/D |
(1,825) |
107,055 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-01-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
4,119 |
108,880 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-01-05 |
4 |
D |
$36.10 |
$783,009 |
D/D |
(21,690) |
104,761 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
